Lakefront Biotherapeutics NV
LKFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421876
No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.
Other share classesGLPGF
Q2 2026 vs. Q1 2026
How the institutions holding Lakefront Biotherapeutics NV changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 90 | 1 | 76 | −13 |
| Shares | 31.3M | 3 | 32.1M | +794.6K (+2.5%) |
| Value | $937.9M | $90 | $960.3M | +$22.5M (+2.4%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Lakefront Biotherapeutics NV at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Norges Bank | 76,879 | $2.30M | 0.00% |
| Schonfeld Strategic Advisors LLC | 32,597 | $977.3K | 0.01% |
| Marshall Wace, LLP | 32,399 | $971.3K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 672 | $20.1K | 0.00% |
| Ronald Blue Trust, Inc. | 249 | $7.46K | 0.00% |
| Eventide Asset Management, LLC | 94 | $2.79K | 0.00% |
| Silver Grove Financial Group, Inc. | 65 | $1.95K | 0.00% |
| First Command Advisory Services, Inc. | 12 | $360 | 0.00% |
Sold out (21)
Institutions that held Lakefront Biotherapeutics NV at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Segall Bryant & Hamill, LLC | 426,412 | $12.8M |
| Old Mission Capital LLC | 95,591 | $2.87M |
| Man Group plc | 80,209 | $2.41M |
| Hudson Bay Capital Management LP | 77,500 | $2.33M |
| Optiver Holding B.V. | 26,535 | $796.0K |
| XTX Topco Ltd | 25,404 | $762.1K |
| Moody National Bank Trust Division | 20,849 | $625.5K |
| Jane Street Group, LLC | 13,607 | $408.2K |
| Voloridge Investment Management, LLC | 13,505 | $405.1K |
| Squarepoint Ops LLC | 12,952 | $388.6K |
| Abc Arbitrage SA | 12,744 | $382.3K |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 8,273 | $248.2K |
| Brinker Capital Investments, LLC | 7,426 | $222.8K |
| Axq Capital, LP | 6,777 | $203.3K |
| Quadrant Capital Group LLC | 3,653 | $109.6K |
| Van Eck Associates Corp | 2,153 | $65.0K |
| Cacti Asset Management LLC | 1,000 | $30.0K |
| State of Wyoming | 991 | $29.7K |
| Larson Financial Group LLC | 286 | $8.58K |
| MAI Capital Management | 70 | $2.10K |
| Bryn Mawr Trust Co | 36 | $1.08K |
Not filed for Q2 2026 yet (1)
Institutions that held Lakefront Biotherapeutics NV at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 3 | $90 |